Clinical Trial

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

Study acronym: IRON-BD
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and laboratory tests before receiving standard-of-care IV iron. Follow-up blood work and questionnaires will be conducted post-replacement to assess for changes
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-16; most recent amendment 2025-10-01.
Status change: Not Yet Recruiting → Recruiting 2025-10-01
Trial Details
NCT Number NCT07083583
Lead Sponsor Nicoletta C Machin
Collaborators: Health Resources and Services Administration (HRSA)
Conditions Bleeding Disorders, Iron, Platelet, Bleeding
Enrollment 40 participants
Start Date 2025-08-08
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-03